Every SEC Form 3/4/5 on record for this filer (CIK 1897057) — 1 issuer, 27 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Chief Accounting Officer | 2021-12-06 → 2026-05-07 | 21 | −$2M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TEVA | 2026-05-06 | Sell | 10,679 | $36.00 | $384,444 | 20,016 |
| TEVA | 2025-12-16 | Sell | 12,300 | $30.20 | $371,460 | 5,650 |
| TEVA | 2025-11-06 | Sell | 12,300 | $24.44 | $300,612 | 17,950 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.